Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Atropine sulfate by Vyluma for Myopia: Likelihood of Approval
Atropine sulfate is under clinical development by Vyluma and currently in Pre-Registration for Myopia. According to GlobalData, Pre-Registration drugs for...